PARADIGM BIOPHARMACEUTICALS LIMITED..

7.79%

35.5¢

Market Cap $141.0M

Healthcare Biotechnology

Paradigm Biopharmaceuticals Limited (ASX:PAR) is an ASX-listed late-stage drug... Paradigm Biopharmaceuticals Limited (ASX:PAR) is an ASX-listed late-stage drug development company focused on delivering new therapies to address unmet medical needs.More

Corporate Spotlight

Paradigm Biopharmaceuticals Limited (ASX:PAR) is an ASX-listed late-stage drug development company focused on delivering new therapies to address unmet medical needs.
View the full Corporate Spotlight

PAR - close to a cure for osteoarthritis?

Latest Threads

Tag

Subject

PAR

Ann: Investor Webinar Presentation

21:28

11K

21:28

Last post Hogana123

11K

PAR

Sharewise Presentation 22/7/24

2 3

30/07/25

144

52K

30/07/25

Last post Duke2

144

52K

PAR

The Phase III Primer!

30/07/25

9.8K

30/07/25

Last post Mozzarc

9.8K

PAR

Ann: June 2025 Quarterly Activities Report & Appendix 4C

29/07/25

3.3K

29/07/25

Last post munchy360

3.3K

PAR

Ann: Paradigm Investor Webinar

29/07/25

4.5K

29/07/25

Last post Mozzarc

4.5K

PAR

Ann: Paradigm Secures US$27M to Advance Phase 3 OA Trial

2 3

29/07/25

133

47K

29/07/25

Last post asx11

133

47K

PAR

Phase 3 Trial progress

28/07/25

16K

28/07/25

Last post strangelogic

16K

PAR

research reports and media

76 77 78

28/07/25

4.6K

2.2M

28/07/25

Last post cocacolamas

4.6K

2.2M

See All Discussions

Timeline

Investor Webinar Presentation
31 Jul 08:56	Share

June 2025 Quarterly Activities Report & Appendix 4C
29 Jul 09:26	Share

Paradigm Investor Webinar
24 Jul 09:22	Share

Application for quotation of securities - PAR
22 Jul 14:57	Share

Notice under Section 708A
07 Jul 16:03	Share

Notification regarding unquoted securities - PAR
07 Jul 14:49	Share

Notice under Section 708A
02 Jul 12:59	Share

Application for quotation of securities - PAR
02 Jul 12:52	Share

Proposed issue of securities - PAR
01 Jul 08:54	Share

Proposed issue of securities - PAR
01 Jul 08:39	Share

Paradigm Secures US$27M to Advance Phase 3 OA Trial
01 Jul 08:31	Share

US Sites Activated and Patients Consented
30 Jun 14:07	Share

Paradigm Strengthens OA Pipeline with Strategic Acquisition
26 Jun 08:27	Share

Phase 3 Knee OA Trial Begins, Site Live, Patient Consented
03 Jun 08:41	Share

Results of Meeting
29 May 17:10	Share

PAR Receives US Ethics Approval for Phase 3
15 May 08:24	Share

Notice of General Meeting/Proxy Form
29 Apr 16:57	Share

March 2025 Quarterly Activities Report & Appendix 4C
29 Apr 13:51	Share

Paradigm to present at NWR Healthcare Conference
18 Mar 15:02	Share

Application for quotation of securities - PAR
14 Mar 15:05	Share

S&P DJI Announces March 2025 Quarterly Rebalance
07 Mar 17:01	Share

Appendix 4D and Half Year Report
28 Feb 08:12	Share

Paradigm Secures Ethics Approval for Phase 3 Trial
24 Feb 08:06	Share

Change of Director's Interest Notice
14 Feb 14:41	Share

Change of Director's Interest Notice
14 Feb 14:41	Share

Listing of Options - Top 20 Holders and Distribution Reports
11 Feb 09:10	Share

Application for quotation of securities - PAR
11 Feb 09:02	Share

Proposed issue of securities - PAR
03 Feb 08:28	Share

Cancel - Proposed issue of securities - PAR
03 Feb 08:28	Share

Proposed issue of securities - PAR
31 Jan 16:29	Share

View More

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 35.5¢		Change -0.030(7.79%)		Mkt cap ! $141.0M

Open	High	Low	Value	Volume
39.5¢	39.5¢	35.0¢	$520.2K	1.422M

Buyers (Bids)

No.	Vol.	Price($)
3	16628	35.0¢

Sellers (Offers)

Price($)	Vol.	No.
36.5¢	20839	3

View Market Depth

No.	Vol.	Price($)
3	16628	0.350
2	36315	0.345
6	91182	0.340
1	5000	0.335
4	69303	0.330

Price($)	Vol.	No.
0.365	20839	3
0.370	6000	1
0.380	7467	1
0.400	14900	1
0.405	18626	1

Last trade - 16.10pm 31/07/2025 (20 minute delay)


Last 36.0¢		Change -0.030 ( 7.69 %)
Open	High	Low	Volume
39.0¢	39.0¢	35.0¢	601265
Last updated 15.59pm 31/07/2025 ?

PAR (ASX) Chart

PARADIGM BIOPHARMACEUTICALS LIMITED..

Corporate Spotlight

Latest Threads

Timeline

Featured News

Latest Videos

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

27 Jun 2025 12:33 (AEST)

This stock could have something close to a cure for osteoarthritis. Don’t let it hide under your nose

21 May 2025 08:34 (AEST)

Latest Articles

Paradigm unlocks $40M loan – and sees a 75cps price not far away

Paradigm Biopharmaceuticals (ASX:PAR) shares were up nearly +25% in morning trades as the company unveiled a loan of around $41 million to advance its osteoarthritis clinical investigations.Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from thr...

Paradigm adds new oral combo IP to osteoarthritis drug stable with $500K pick-up

Paradigm Biopharmaceuticals (ASX:PAR) has acquired the exclusive global rights to develop @ and, of course, commercialise @ a novel oral combination of PPS and a COX-2 inhibitor designed to treat osteoarthritis and pains.Listen to the HotCopper podcast for in-depth discussions and insights on all...

Paradigm activates first Aus site for osteoarthritis drug trials

Paradigm Biopharmaceuticals Ltd has opened its first Australian site as part of a trial to assess injectable pentosan polysulfate sodium

Buyers (Bids)

Sellers (Offers)

Infini Resources appoints Rohan Bone as CEO ahead of Phase 2 campaign

Resolution Minerals appoints industry experts to fast-track US growth strategy

A new NASDAQ listing for a key player in the global critical minerals space

Top Stories

Featured News